After several issues involving rare blood clots, the FDA will now limit who should receive the Johnson & Johnson vaccine.
Click ▶️ to listen to Jamie Jackson’s report:
by
After several issues involving rare blood clots, the FDA will now limit who should receive the Johnson & Johnson vaccine.
Click ▶️ to listen to Jamie Jackson’s report: